Authors:
Mathai, D
Lewis, MT
Kugler, KC
Pfaller, MA
Jones, RN
Citation: D. Mathai et al., Antibacterial activity of 41 antimicrobials tested against over 2773 bacterial isolates from hospitalized patients with pneumonia: I - results from the SEMTRY Antimicrobial Surveillance Program (North America, 1998) (vol 39,pg 105, 2001), DIAG MICR I, 39(4), 2001, pp. 275-275
Authors:
Mathai, D
Lewis, MT
Kugler, KC
Pfaller, MA
Jones, RN
Citation: D. Mathai et al., Antibacterial activity of 41 antimicrobials tested against over 2773 bacterial isolates from hospitalized patients with pneumonia: I - results from the SENTRY Antimicrobial Surveillance Program (North America, 1998), DIAG MICR I, 39(2), 2001, pp. 105-116
Citation: Sa. Marshall et al., Evaluation of quinupristin/dalfopristin (Synercid (R)) and RPR 106 972 stability in susceptibility testing media, INT J ANT A, 15(4), 2000, pp. 291-297
Authors:
Diekema, DJ
Pfaller, MA
Jones, RN
Doern, GV
Kugler, KC
Beach, ML
Sader, HS
Citation: Dj. Diekema et al., Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections in the USA, Canada and Latin America, INT J ANT A, 13(4), 2000, pp. 257-271
Authors:
Jones, RN
Croco, MAT
Kugler, KC
Pfaller, MA
Beach, ML
Citation: Rn. Jones et al., Respiratory tract pathogens isolated from patients hospitalized with suspected pneumonia: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997), DIAG MICR I, 37(2), 2000, pp. 115-125
Authors:
Kugler, KC
Denys, GA
Wilson, ML
Jones, RN
Citation: Kc. Kugler et al., Serious streptococcal infections produced by isolates resistant to streptogramins (quinupristin/dalfopristin): Case reports from the SENTRY antimicrobial surveillance program, DIAG MICR I, 36(4), 2000, pp. 269-272
Authors:
Jones, RN
Kugler, KC
Pfaller, MA
Winokur, PL
Citation: Rn. Jones et al., Characteristics of pathogens causing urinary tract infections in hospitalsin North America: Results from the SENTRY Antimicrobial Surveillance Program, 1997, DIAG MICR I, 35(1), 1999, pp. 55-63
Authors:
Doern, GV
Jones, RN
Pfaller, MA
Kugler, KC
Beach, ML
Citation: Gv. Doern et al., Bacterial pathogens isolated from patients with skin and soft tissue infections: Frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada,1997), DIAG MICR I, 34(1), 1999, pp. 65-72
Citation: Kc. Kugler et al., Determination of the antimicrobial activity of 29 clinically important compounds tested against fastidious HACEK group organisms, DIAG MICR I, 34(1), 1999, pp. 73-76
Authors:
Jones, RN
Kugler, KC
Erwin, ME
Biedenbach, DJ
Beach, ML
Pfaller, MA
Citation: Rn. Jones et al., Gatifloxacin (AM-1155, CG 5501) susceptibility testing interpretive criteria and quality control guidelines for dilution and disk (5-mu g) diffusion methods, DIAG MICR I, 33(4), 1999, pp. 247-253
Authors:
Pfaller, MA
Jones, RN
Doern, GV
Sader, HS
Kugler, KC
Beach, ML
Citation: Ma. Pfaller et al., Survey of blood stream infections attributable to Gram-positive cocci: Frequency of occurrence and antimicrobial susceptibility of isolates collectedin 1997 in the United States, Canada, and Latin America from the SENTRY Antimicrobial Surveillance Program, DIAG MICR I, 33(4), 1999, pp. 283-297
Authors:
Sader, HS
Jones, RN
Gales, AC
Winokur, P
Kugler, KC
Pfaller, MA
Doern, GV
Citation: Hs. Sader et al., Antimicrobial susceptibility patterns for pathogens isolated from patientsin Latin American medical centers with a diagnosis of pneumonia: Analysis of results from the SENTRY Antimicrobial Surveillance Program (1997), DIAG MICR I, 32(4), 1998, pp. 289-301